ARTICLE | Clinical News
SmithKline Beecham Biologicals regulatory update
January 4, 1999 8:00 AM UTC
The FDA granted marketing approval for SmithKline's Lymerix vaccine containing recombinant outer-surface lipoprotein A (OspA) of Borrelia burgdorferi to prevent Lyme disease. ...